DSS Inc

DSS Inc(DSS)股票分析

$0.510

-0.007 (-1.39%)收盤時

Loading chart…
最高
0.548
開盤
0.510
成交量加權均價
0.52
成交量
8.78K
市值
12.39M
最低
0.510
成交金額
4.59K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

AI 分析 of DSS Inc (DSS)

賣出

DSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.

估值指標

DSS Inc(DSS)目前預期本益比為 0.00,5 年平均預期本益比為 -1.42。

預期本益比

高估
5 年均值 P/E
-1.42
目前P/E
0.00
高估
-0.57
低估
-2.26

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-5.89
目前EV/EBITDA
0.00
高估
1.04
低估
-12.82

預期股價營收比

低估
5 年均值 P/S
0.64
目前P/S
0.00
高估
1.01
低估
0.27

Alphio AI 對 DSS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%DSS

$0.63

情境價格

基

基準

基準 · 50%DSS

$0.63

情境價格

悲

悲觀

悲觀 · 25%DSS

$0.61

情境價格

事件時間軸

2026-09-04 (ET)

09:00:00

DSS, Inc. Cancels Proposed Public Offering

2026-09-03 (ET)

21:00:00

DSS Commences Public Offering of Common Stock

2026-05-08 (ET)

17:10:00

DSS Annual Report Contains Going Concern Audit Opinion

2026-02-04 (ET)

08:40:00

DSS Prices Public Offering Expected to Raise $1M

2026-02-03 (ET)

20:30:00

Aegis Capital Acts as Sole Underwriter for Offering

資訊

DSS 常見問題 —— 由 Alphio AI 解答

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).

DSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易